Terms: = Lymphoma AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG AND Prognosis
12 results:
1. Prognostic Value of Microvessel Density in Non-Hodgkin lymphoma: A Meta-Analysis.
Wu J; Ma S; Sun L; Qin Z; Wang Z; Wang N; Lin M
Acta Haematol; 2021; 144(6):603-612. PubMed ID: 34044389
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic impact of maximum standardized uptake value on
Qiu X; Liang H; Zhong W; Zhao J; Chen M; Zhu Z; Xu Y; Wang M
Thorac Cancer; 2021 Mar; 12(6):845-853. PubMed ID: 33512768
[TBL] [Abstract] [Full Text] [Related]
3. [Clinical analysis of a modified LMB89 Group C regimen in the treatment of pediatric high-risk Burkitt lymphoma].
Zhang M; Jin L; Yang J; Duan YL; Huang S; Zhou CJ; Zhang YH
Zhonghua Xue Ye Xue Za Zhi; 2019 Aug; 40(8):633-638. PubMed ID: 31495128
[No Abstract] [Full Text] [Related]
4. FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas.
Brown PJ; Wong KK; Felce SL; Lyne L; Spearman H; Soilleux EJ; Pedersen LM; Møller MB; Green TM; Gascoyne DM; Banham AH
Leukemia; 2016 Mar; 30(3):605-16. PubMed ID: 26500140
[TBL] [Abstract] [Full Text] [Related]
5. The impact of IKZF1 deletion on the prognosis of acute lymphoblastic leukemia: an updated meta-analysis.
Jia M; Wang ZJ; Li JY; Yang SL; Zhao HZ; Cheng YP; Luo ZB; Tang YM
Cancer Biomark; 2014; 14(6):493-503. PubMed ID: 25335741
[TBL] [Abstract] [Full Text] [Related]
6. Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study.
Gatta G; Botta L; Rossi S; Aareleid T; Bielska-Lasota M; Clavel J; Dimitrova N; Jakab Z; Kaatsch P; Lacour B; Mallone S; Marcos-Gragera R; Minicozzi P; Sánchez-Pérez MJ; Sant M; Santaquilani M; Stiller C; Tavilla A; Trama A; Visser O; Peris-Bonet R;
Lancet Oncol; 2014 Jan; 15(1):35-47. PubMed ID: 24314616
[TBL] [Abstract] [Full Text] [Related]
7. Smoking, alcohol use, obesity, and overall survival from non-Hodgkin lymphoma: a population-based study.
Geyer SM; Morton LM; Habermann TM; Allmer C; Davis S; Cozen W; Severson RK; Lynch CF; Wang SS; Maurer MJ; Hartge P; Cerhan JR
Cancer; 2010 Jun; 116(12):2993-3000. PubMed ID: 20564404
[TBL] [Abstract] [Full Text] [Related]
8. Ki-67 expression as a prognostic factor in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP.
Yoon DH; Choi DR; Ahn HJ; Kim S; Lee DH; Kim SW; Park BH; Yoon SO; Huh J; Lee SW; Suh C
Eur J Haematol; 2010 Aug; 85(2):149-57. PubMed ID: 20477862
[TBL] [Abstract] [Full Text] [Related]
9. High dose chemoradiotherapy and ASCT may overcome the prognostic importance of biologic markers in relapsed/refractory Hodgkin lymphoma.
Persky DO; Moskowitz CH; Filatov A; Saxena R; Cui H; Teruya-Feldstein J
Appl Immunohistochem Mol Morphol; 2010 Jan; 18(1):35-40. PubMed ID: 19701081
[TBL] [Abstract] [Full Text] [Related]
10. Histiocyte-rich B-cell lymphoma.
Sun T; Susin M; Tomao FA; Brody J; Koduru P; Hajdu SI
Hum Pathol; 1997 Nov; 28(11):1321-4. PubMed ID: 9385944
[TBL] [Abstract] [Full Text] [Related]
11. [Prognostic factors and mortality among adult patients with acute leukemia and infection].
Brodsky AL; Melero MJ; Minissale C; Sánchez Avalos JC
Medicina (B Aires); 1997; 57(5):557-65. PubMed ID: 9674224
[TBL] [Abstract] [Full Text] [Related]
12. Primary cutaneous B-cell lymphoma: a unique type of low-grade lymphoma. Clinicopathologic and immunologic study of 83 cases.
Santucci M; Pimpinelli N; Arganini L
Cancer; 1991 May; 67(9):2311-26. PubMed ID: 2013039
[TBL] [Abstract] [Full Text] [Related]
